NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT04826198 2024-12-05REVOCANGustave Roussy, Cancer Campus, Grand ParisPhase 1/2 Terminated13 enrolled